The chief executive of AstraZeneca said on Tuesday that the drugmaker will maintain its 2025 sales guidance even if the U.S.

British pharmaceutical giant AstraZeneca reported a rise in first-quarter profit on Tuesday, driven by strong sales growth in ...

On a per-share basis, the Cambridge, Britain-based company said it had profit of 93 cents. Earnings, adjusted for non-recurring costs, came to $1.24 per share. The results topped Wall Street ...

AstraZeneca may face a fine of up to $8 million in China over suspected unpaid taxes related to the import of its breast ...

AstraZeneca PLC closed 21.38% short of its 52-week high of £133.88, which the company achieved on September 3rd.

AstraZeneca on Tuesday said it may face a fine of up to $8 million over suspected unpaid import taxes in China as the ...

AstraZeneca plots US expansion despite Trump tariff threat - The drug maker said it is ‘firmly committed to investing and ...

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader in data-driven medicine, today ...

HR Path, a global leader in HR consulting and HRIS solutions, is proud to announce its strategic acquisition of smahrt ...

The Middle East isn't just adopting digital transformation?it's engineering the future of banking with bold leadership, smart regulation, and rapid AI investment. It is in this spirit of ...

AstraZeneca recorded USD13.59 billion in total revenue in the first quarter of 2025, up 7.2% from USD12.68 billion a year before, and up 10% at constant exchange rates. This lifted pretax profit by 21 ...